02/13
Headlines

NASDAQ:RXDX

Market Movers : Breitburn Energy Partners L.P. (NASDAQ:BBEP), Petroleo Brasileiro Petrobras (NYSE:PBR), Ciena Corporation (NYSE:CIEN), Ignyta, Inc. (NASDAQ:RXDX), Apple Inc. (NASDAQ:AAPL)

John Meady03 mins

BreitBurn Energy Partners L.P. (NASDAQ:BBEP) announced today the pricing of its public offering of 14,000,000 common units representing limited partner interests in Breitburn (Common Units) at a price to the public of $18.64 per Common Unit. Breitburn has granted to the underwriters a 30-day option to purchase up to an additional 2,100,000 Common Units to…

Read More

Healthcare Decliners: Aldeyra Therapeutics (NASDAQ:ALDX), Ignyta (NASDAQ:RXDX), Vital Therapies (NASDAQ:VTL), Actinium (NYSEMKT:ATNM), TrovaGene (NASDAQ:TROV)

Jayne Crisman03 mins

Aldeyra Therapeutics Inc (NASDAQ:ALDX) quiet period is set to expire on Wednesday, June 11th. Aldeyra Therapeutics had issued 1,500,000 shares in its IPO on May 2nd, AR Network reports. The total size of the offering was $12,000,000 based on an initial share price of $8.00. Aldeyra Therapeutics Inc (NASDAQ:ALDX) stock performance was -7.08% in last…

Read More

Biotech Decliners: Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX), Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Corcept Therapeutics Incorporated (NASDAQ:CORT)

Mark Doerr03 mins

Aegis started coverage on shares of Recro Pharma Inc. (NASDAQ:REPH) in a research note issued on Thursday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $40.00 price target on the stock. Aegis’ price objective suggests a potential upside of 412.16% from the company’s current price. Recro Pharma Inc (NASDAQ:REPH) stock performance was -7.30%…

Read More

Biotech Gainers: Ignyta Inc (NASDAQ:RXDX), Onconova Therapeutics Inc (NASDAQ:ONTX), Cempra Inc (NASDAQ:CEMP), ANI Pharmaceuticals Inc (NASDAQ:ANIP)

Chris Lewis02 mins

Ignyta Inc (NASDAQ:RXDX) released its earnings data. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.37) by $0.09. Finally, analysts at Ladenburg Thalmann initiated coverage on shares of company in a research note on Monday, March 24th. They set a “buy” rating and a $20.00 price target…

Read More

Biotech Bullish Stocks: Galmed Pharmaceuticals Ltd (NASDAQ:GLMD), Reliv International, Inc (NASDAQ:RELV), Recro Pharma Inc (NASDAQ:REPH), Ignyta Inc (NASDAQ:RXDX)

Colin Pettis02 mins

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) has seen a massive down tick in the past few trading sessions, and analysts believe that this downward trajectory might continue for the stock and may lead it to lower levels. Short term traders can short the stock at current levels with a tight stop loss at $11 for targets of…

Read More